Quarterly report · Q2
9438.TEDINET S100QQRZ
Period2022-10-01 → 2023-03-31
Filed2023-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Amended by S100SBOM (2023-11-20).
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.6bn | 2022-10-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥26.5bn | 2021-10-01 → 2022-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥13.0bn | 2021-10-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | −¥19m | 2022-10-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥599m | 2021-10-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥187m | 2022-10-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥486m | 2021-10-01 → 2022-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥293m | 2021-10-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥291m | 2022-10-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥363m | 2021-10-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥326m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥930m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥123m | 2021-10-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥401m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥4m | 2021-10-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥28.9bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥29.3bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥29.2bn | at 2022-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥11.8bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥11.4bn | at 2022-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥17.1bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥17.9bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥19.2bn | at 2022-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥12.8bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥12.1bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥12.8bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.1bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.6bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.5bn | at 2021-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.1bn | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.4bn | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥788m | 2021-10-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥616m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.5bn | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.4bn | 2021-10-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥798m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥344m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥776m | 2021-10-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-5.95 | 2022-10-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥4.82 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-16.99 | 2021-10-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥2.25 | 2021-10-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-2.36 | 2022-01-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥2.25 | 2021-10-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 46.2% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.1% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.9% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-10-01 → 2023-03-31 | −¥858m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-10-01 → 2023-03-31 | −¥858m |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-03-31 | −¥1.3bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥9.5bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥9.3bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥153m |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥2.8bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥2.2bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥2.2bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥5m |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥220m |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥2.4bn |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥1.7bn |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥699m |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥807m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥309m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥309m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥461m |
| —segment total | revenue | 2022-10-01 → 2023-03-31 | ¥14.5bn |
| —segment total | revenue external | 2022-10-01 → 2023-03-31 | ¥13.6bn |
| —segment total | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥858m |
| —segment total | segment profit | 2022-10-01 → 2023-03-31 | ¥1.3bn |
| Reconciling Itemsreconciling | revenue | 2021-10-01 → 2022-03-31 | −¥646m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-10-01 → 2022-03-31 | −¥646m |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-03-31 | −¥1.2bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥9.1bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥9.0bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue intersegment | 2021-10-01 → 2022-03-31 | ¥112m |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | segment profit | 2021-10-01 → 2022-03-31 | ¥2.9bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥1.9bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥1.9bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue intersegment | 2021-10-01 → 2022-03-31 | ¥10m |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | segment profit | 2021-10-01 → 2022-03-31 | −¥649m |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥2.5bn |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥2.0bn |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue intersegment | 2021-10-01 → 2022-03-31 | ¥524m |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | segment profit | 2021-10-01 → 2022-03-31 | −¥176m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥121m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥121m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | segment profit | 2021-10-01 → 2022-03-31 | −¥233m |
| —segment total | revenue | 2021-10-01 → 2022-03-31 | ¥13.6bn |
| —segment total | revenue external | 2021-10-01 → 2022-03-31 | ¥13.0bn |
| —segment total | revenue intersegment | 2021-10-01 → 2022-03-31 | ¥646m |
| —segment total | segment profit | 2021-10-01 → 2022-03-31 | ¥1.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 540
| Item | Context | Value | Unit |
|---|---|---|---|
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | 48174000 | JPY |
| Increase decrease in accounts payable other ope cf | Prior1YTDDuration | -15307000 | JPY |
| Increase decrease in accounts payable other ope cf | CurrentYTDDuration | -51997000 | JPY |
| Decrease increase in consumption taxes receivable payable ope cf | Prior1YTDDuration | -481879000 | JPY |
| Decrease increase in consumption taxes receivable payable ope cf | CurrentYTDDuration | 1057174000 | JPY |
| Other net ope cf | Prior1YTDDuration | 26608000 | JPY |
| Other net ope cf | CurrentYTDDuration | -74319000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 1127293000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | 1656119000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 62000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 52000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -2892000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -6135000 | JPY |
| Income taxes paid refund ope cf | Prior1YTDDuration | -1912569000 | JPY |
| Income taxes paid refund ope cf | CurrentYTDDuration | 455911000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | -788106000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | 2105948000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YTDDuration | -39979000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -36079000 | JPY |
| Purchase of intangible assets inv cf | Prior1YTDDuration | -1336048000 | JPY |
| Purchase of intangible assets inv cf | CurrentYTDDuration | -583419000 | JPY |
| Proceeds from sales of investment securities inv cf | Prior1YTDDuration | 16196000 | JPY |
| Proceeds from sales of investment securities inv cf | CurrentYTDDuration | 1504000 | JPY |
| Payments for transfer of business2 inv cf | Prior1YTDDuration | -44500000 | JPY |
| Payments for transfer of business2 inv cf | CurrentYTDDuration | － | JPY |
| Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | Prior1YTDDuration | -29000000 | JPY |
| Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | CurrentYTDDuration | － | JPY |
| Proceeds from purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | Prior1YTDDuration | 14014000 | JPY |
| Proceeds from purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | CurrentYTDDuration | － | JPY |
| Other net inv cf | Prior1YTDDuration | 5417000 | JPY |
| Other net inv cf | CurrentYTDDuration | 1629000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -1413899000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -616364000 | JPY |
| Increase in short term loans payable fin cf | Prior1YTDDuration | 204000 | JPY |
| Increase in short term loans payable fin cf | CurrentYTDDuration | 60000000 | JPY |
| Decrease in short term loans payable fin cf | Prior1YTDDuration | － | JPY |
| Decrease in short term loans payable fin cf | CurrentYTDDuration | -50975000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -250545000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -375890000 | JPY |
| Proceeds from issuance of common stock fin cf | Prior1YTDDuration | 28660000 | JPY |
| Proceeds from issuance of common stock fin cf | CurrentYTDDuration | 27132000 | JPY |
| Repayments to non controlling shareholders fin cf | Prior1YTDDuration | － | JPY |
| Repayments to non controlling shareholders fin cf | CurrentYTDDuration | -2940000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -439609000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -440095000 | JPY |
| Dividends paid to non controlling interests fin cf | Prior1YTDDuration | － | JPY |
| Dividends paid to non controlling interests fin cf | CurrentYTDDuration | -2940000 | JPY |
| Payments from changes in ownership interests in subsidiaries that do not result in change in scope of consolidation fin cf | Prior1YTDDuration | -85400000 | JPY |
| Payments from changes in ownership interests in subsidiaries that do not result in change in scope of consolidation fin cf | CurrentYTDDuration | -12500000 | JPY |
| Purchase of treasury stock of subsidiaries in consolidation fin cf | Prior1YTDDuration | -29800000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |